{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "I",
                    "alt": "V",
                    "position": "1122"
                },
                "variant_string_id": "LRRK2 I1122V"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Dominant mutations in the LRRK2 gene, coding for the protein dardarin, are a common cause of inherited Parkinson disease (PD). Patients with LRRK2/dardarin mutations show loss of striatal 18F - DOPA PET signal, consistent with loss of presynaptic neurons projecting from the substantia nigra pars compacta to the striatum. Post - mortem examination reveals loss of nigral neurons, often with Lewy bodies, and other variable protein inclusions. The dardarin protein has multiple domains, and mutations in it may lead to cell loss and variable protein inclusion pathology.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to LRRK2 mutations in PD, including the role of the protein's domains and the resulting cellular and pathological changes.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used transfection of wild - type and mutant dardarin into various cell lines (COS7, HEK293, SH - SY5Y) and primary rat cortical neurons to observe cellular phenotypes such as inclusion body formation and cell death. These assays model the cellular effects of mutant dardarin relevant to the disease mechanism of PD.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the cellular changes seen in PD patients with LRRK2 mutations, thus reflecting the disease pathogenesis defined in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For the toxicity assays, four replicate transfections were used, with at least 50 cells counted per culture. In the in vitro autophosphorylation assay, quadruplicate samples were used. For the experiments in primary rat cortical neurons, four primary cultures were used per construct. Basic controls such as untransfected cells were used in the autophosphorylation assay, and normal (wild - type) and abnormal (mutant) conditions were compared in the cellular phenotype assays.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (untransfected cells in autophosphorylation and comparison of wild - type and mutant in cellular phenotype assays) and multiple replicates were used in the experiments, meeting the requirements of this step.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls (if basic controls/replicates were sufficient in 3a)",
                    "extracted_paper_info": "The study compared the effects of wild - type dardarin with those of multiple pathogenic mutants (I1122V, R1441C, Y1699C, G2019S, I2020T) in various assays.",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic variants were used as controls, fulfilling the condition for this sub - step.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Quantitative data on the proportion of cells with inclusion bodies and cell death were analyzed by ANOVA. For example, the proportion of transfected cells that contained inclusion bodies was quantified, and the differences between wild - type and mutant were analyzed by ANOVA (P < 0.05), and the difference between pathogenic mutations on kinase - active and kinase - dead backgrounds were also significant (P < 0.001).",
                    "judgment": "Yes",
                    "reasoning": "Statistical analyses were used to estimate the effects of the variant, fulfilling the condition for this step.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
                    "extracted_paper_info": "Although OddsPath was not directly calculated, the statistical significance of the differences between wild - type and mutant dardarin in terms of inclusion body formation and cell death was demonstrated through ANOVA. For example, the proportion of cells with inclusion bodies was significantly different between wild - type and mutant (P < 0.05), and between kinase - active and kinase - dead mutants (P < 0.001).",
                    "judgment": "Based on the significant statistical differences, the functional evidence strength can be considered as PS3_moderate",
                    "reasoning": "The significant statistical differences suggest a moderate level of evidence for the pathogenicity of the variant, similar to the level expected for PS3_moderate according to ACMG guidelines.",
                    "next_step_or_outcome": ""
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The LRRK2 I1122V variant was shown to cause inclusion body formation and cell death in cell models. The disease mechanism was well - defined, the assays were applicable and valid with appropriate controls and replicates. Statistical analyses demonstrated significant differences between wild - type and mutant, leading to a PS3_moderate strength rating for pathogenicity."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "C",
                    "position": "1441"
                },
                "variant_string_id": "LRRK2 R1441C"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Dominant mutations in the LRRK2 gene, coding for the protein dardarin, are a common cause of inherited Parkinson disease (PD). Patients with LRRK2/dardarin mutations show loss of striatal 18F - DOPA PET signal, consistent with loss of presynaptic neurons projecting from the substantia nigra pars compacta to the striatum. Post - mortem examination reveals loss of nigral neurons, often with Lewy bodies, and other variable protein inclusions. The dardarin protein has multiple domains, and mutations in it may lead to cell loss and variable protein inclusion pathology.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to LRRK2 mutations in PD, including the role of the protein's domains and the resulting cellular and pathological changes.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used transfection of wild - type and mutant dardarin into various cell lines (COS7, HEK293, SH - SY5Y) and primary rat cortical neurons to observe cellular phenotypes such as inclusion body formation and cell death. These assays model the cellular effects of mutant dardarin relevant to the disease mechanism of PD.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the cellular changes seen in PD patients with LRRK2 mutations, thus reflecting the disease pathogenesis defined in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For the toxicity assays, four replicate transfections were used, with at least 50 cells counted per culture. In the in vitro autophosphorylation assay, quadruplicate samples were used. For the experiments in primary rat cortical neurons, four primary cultures were used per construct. Basic controls such as untransfected cells were used in the autophosphorylation assay, and normal (wild - type) and abnormal (mutant) conditions were compared in the cellular phenotype assays.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (untransfected cells in autophosphorylation and comparison of wild - type and mutant in cellular phenotype assays) and multiple replicates were used in the experiments, meeting the requirements of this step.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls (if basic controls/replicates were sufficient in 3a)",
                    "extracted_paper_info": "The study compared the effects of wild - type dardarin with those of multiple pathogenic mutants (I1122V, R1441C, Y1699C, G2019S, I2020T) in various assays.",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic variants were used as controls, fulfilling the condition for this sub - step.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Quantitative data on the proportion of cells with inclusion bodies and cell death were analyzed by ANOVA. For example, the proportion of transfected cells that contained inclusion bodies was quantified, and the differences between wild - type and mutant were analyzed by ANOVA (P < 0.05), and the difference between pathogenic mutations on kinase - active and kinase - dead backgrounds were also significant (P < 0.001). The number of cells with nuclear shrinkage (cell death) was also quantified and analyzed by two - way ANOVA (P < 0.001).",
                    "judgment": "Yes",
                    "reasoning": "Statistical analyses were used to estimate the effects of the variant, fulfilling the condition for this step.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
                    "extracted_paper_info": "Although OddsPath was not directly calculated, the statistical significance of the differences between wild - type and mutant dardarin in terms of inclusion body formation and cell death was demonstrated through ANOVA. For example, R1441C mutant dardarin induced significant cell death compared to wild - type (P < 0.05), and the kinase - dead version had a significantly different effect (P < 0.001).",
                    "judgment": "Based on the significant statistical differences, the functional evidence strength can be considered as PS3_moderate",
                    "reasoning": "The significant statistical differences suggest a moderate level of evidence for the pathogenicity of the variant, similar to the level expected for PS3_moderate according to ACMG guidelines.",
                    "next_step_or_outcome": ""
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The LRRK2 R1441C variant was shown to cause inclusion body formation and cell death in cell models. The disease mechanism was well - defined, the assays were applicable and valid with appropriate controls and replicates. Statistical analyses demonstrated significant differences between wild - type and mutant, leading to a PS3_moderate strength rating for pathogenicity."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "Y",
                    "alt": "C",
                    "position": "1699"
                },
                "variant_string_id": "LRRK2 Y1699C"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Dominant mutations in the LRRK2 gene, coding for the protein dardarin, are a common cause of inherited Parkinson disease (PD). Patients with LRRK2/dardarin mutations show loss of striatal 18F - DOPA PET signal, consistent with loss of presynaptic neurons projecting from the substantia nigra pars compacta to the striatum. Post - mortem examination reveals loss of nigral neurons, often with Lewy bodies, and other variable protein inclusions. The dardarin protein has multiple domains, and mutations in it may lead to cell loss and variable protein inclusion pathology.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to LRRK2 mutations in PD, including the role of the protein's domains and the resulting cellular and pathological changes.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used transfection of wild - type and mutant dardarin into various cell lines (COS7, HEK293, SH - SY5Y) and primary rat cortical neurons to observe cellular phenotypes such as inclusion body formation and cell death. These assays model the cellular effects of mutant dardarin relevant to the disease mechanism of PD.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the cellular changes seen in PD patients with LRRK2 mutations, thus reflecting the disease pathogenesis defined in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For the toxicity assays, four replicate transfections were used, with at least 50 cells counted per culture. In the in vitro autophosphorylation assay, quadruplicate samples were used. For the experiments in primary rat cortical neurons, four primary cultures were used per construct. Basic controls such as untransfected cells were used in the autophosphorylation assay, and normal (wild - type) and abnormal (mutant) conditions were compared in the cellular phenotype assays.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (untransfected cells in autophosphorylation and comparison of wild - type and mutant in cellular phenotype assays) and multiple replicates were used in the experiments, meeting the requirements of this step.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls (if basic controls/replicates were sufficient in 3a)",
                    "extracted_paper_info": "The study compared the effects of wild - type dardarin with those of multiple pathogenic mutants (I1122V, R1441C, Y1699C, G2019S, I2020T) in various assays.",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic variants were used as controls, fulfilling the condition for this sub - step.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Quantitative data on the proportion of cells with inclusion bodies and cell death were analyzed by ANOVA. For example, the proportion of transfected cells that contained inclusion bodies was quantified, and the differences between wild - type and mutant were analyzed by ANOVA (P < 0.05), and the difference between pathogenic mutations on kinase - active and kinase - dead backgrounds were also significant (P < 0.001). The number of transfected TUNEL - positive cells (indicating cell death) was also analyzed, with Y1699C mutant increasing the number and the kinase - dead version decreasing it significantly (P < 0.01).",
                    "judgment": "Yes",
                    "reasoning": "Statistical analyses were used to estimate the effects of the variant, fulfilling the condition for this step.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
                    "extracted_paper_info": "Although OddsPath was not directly calculated, the statistical significance of the differences between wild - type and mutant dardarin in terms of inclusion body formation and cell death was demonstrated through ANOVA. For example, Y1699C mutant dardarin induced significant cell death and inclusion body formation compared to wild - type, and the kinase - dead version had a significantly different effect.",
                    "judgment": "Based on the significant statistical differences, the functional evidence strength can be considered as PS3_moderate",
                    "reasoning": "The significant statistical differences suggest a moderate level of evidence for the pathogenicity of the variant, similar to the level expected for PS3_moderate according to ACMG guidelines.",
                    "next_step_or_outcome": ""
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The LRRK2 Y